Wagner Klaus W.

Chief Medical OfficerBoundless Bio, Inc. (BOLD) · full profile →Form 4 · filed Aug 20, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
0 non-derivative · 10 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 19, 2024Disposed to issuer(D)103K0
Aug 19, 2024Disposed to issuer(D)10K0
Aug 19, 2024Disposed to issuer(D)95K0
Aug 19, 2024Disposed to issuer(D)68K0
Aug 19, 2024Grant(A)42K42K
Aug 19, 2024Grant(A)103K103K
Aug 19, 2024Grant(A)10K10K
Aug 19, 2024Grant(A)95K95K
Aug 19, 2024Grant(A)68K68K
Aug 19, 2024Disposed to issuer(D)42K0

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-099299) within minutes of acceptance. Every field above traces to the original document. Verify it directly: